What Happened?
Cambridge, MA-based 2seventy Bio Promoted Susan Abu-Absi as Chief Technology and Manufacturing Officer
About the Company
We are an immuno-oncology cell therapy company focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. Our name, 2seventy Bio, is inspired by the maximum speed of translating human thought into action—270 miles per hour, and at 2seventy, we think in the language of time. With a deep understanding of cancer cell metabolism, genomics, and the human body`s immune response to tumor cells, we`re applying this knowledge and expertise to new classes of cellular therapies that are designed to “think” smarter and faster than cancer. It is this mindset that propels us forward because we know that time matters -- every day, every minute, every second -- to people living with cancer
About the Person
Susan Abu-Absi is Chief Technology and Manufacturing Officer at 2seventy Bio. Previously, Susan held various senior IT leadership roles in the industry.
Info Source
News
Short Profile